Tag Archives: U.S.

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

Viewpoints: Simplify Regulations That Keep Diagnostic Innovations Out Of Hands Of U.S. Physicians; New Opioid Policies Bring Harm To Patients Who Need Them

Editorial writers focus on these health topics and others. Stat: Diagnostic Innovations Are Slowed By Bureaucratic Roadblocks Imagine, for a minute, that you are a cardiologist working in the emergency department of a busy hospital. You have several patients with chest pain: some of them are having heart attacks, or are about to; others have… Read More »

Sen. Sanders, Rep. Cummings to introduce bill to lower U.S. drug prices

WASHINGTON (Reuters) – U.S. Senator Bernie Sanders and Representative Elijah Cummings plan to introduce legislation on Thursday aimed at lowering the cost of prescription drugs for U.S. consumers. FILE PHOTO: A pharmacy employee looks for medication as she works to fill a prescription while working at a pharmacy in New York December 23, 2009. REUTERS/Lucas… Read More »